[MYGN] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
07-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -60.42%
YoY- 444.07%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 202,300 200,900 193,500 194,000 190,200 200,500 196,900 1.81%
PBT 800 16,100 16,500 3,700 86,600 18,800 8,000 -78.42%
Tax 1,600 3,000 5,200 -28,400 5,600 6,100 3,800 -43.79%
NP -700 13,100 11,400 32,100 81,100 12,900 4,200 -
Tax Rate -200.00% -18.63% -31.52% 767.57% -6.47% -32.45% -47.50% -
Total Cost 203,000 187,800 182,100 161,900 109,100 187,600 192,700 3.52%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin -0.35 6.52 5.89 16.55 42.64 6.43 2.13 -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -0.01 0.19 0.16 0.46 1.18 0.19 0.06 -
EPS Diluted -0.01 0.18 0.16 0.45 1.15 0.19 0.06 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.